Inventiva (IVA) Appoints Chris Venezia as Chief Operating Officer
IVA Inventiva ADR
$4.68 -0.53%
View chart & analysis → - 1Inventiva S.A. (IVA) announced the appointment of Chris Venezia as Chief Operating Officer.
- 2With 30 years of biopharmaceutical leadership, including as former CEO of Motric Bio, he will oversee operations and launch readiness.
- 3The company is preparing for commercialization ahead of the NATiV3 Phase 3 results for lanifibranor in MASH, expected in Q4 2026.
This 3-line summary is compiled from the report below.
The Wall Street Journal +1 View original ↗숨기는 것 없이, 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다